Latest Articles
AstraZeneca’s DESTINY-Endometrial01: A New Frontier in Endometrial Cancer Treatment - TipRanks
AstraZeneca’s DESTINY-Endometrial01: A New Frontier in Endometrial Cancer Treatment TipRanks
Published: Aug. 24, 2025, 4:50 p.m.
World-first therapy to target endometriosis and deadly cancer - Herald Sun
World-first therapy to target endometriosis and deadly cancer Herald Sun
Published: Aug. 24, 2025, noon
5 Subtle Signs of Endometrial Cancer You Should Never Ignore, According to Doctors - aol.com
5 Subtle Signs of Endometrial Cancer You Should Never Ignore, According to Doctors aol.com
Published: Aug. 23, 2025, 9:57 p.m.
World-first therapy to target endometriosis and deadly cancer - The Mercury
World-first therapy to target endometriosis and deadly cancer The Mercury
Published: Aug. 23, 2025, 7:06 p.m.
World-first therapy to target endometriosis and deadly cancer - Gold Coast Bulletin
World-first therapy to target endometriosis and deadly cancer Gold Coast Bulletin
Published: Aug. 23, 2025, 7:02 p.m.
AstraZeneca’s DESTINY-Endometrial01 Study: A New Horizon in Endometrial Cancer Treatment - TipRanks
AstraZeneca’s DESTINY-Endometrial01 Study: A New Horizon in Endometrial Cancer Treatment TipRanks
Published: Aug. 23, 2025, 6:45 a.m.
Surgical Outcomes of Open, Laparoscopic, and Robotic-Assisted Approaches for Stage I Endometrial Cancer: Insights From a Real-World Study by the Indian Gynecologic-Onco Study Group - Cureus
Surgical Outcomes of Open, Laparoscopic, and Robotic-Assisted Approaches for Stage I Endometrial Cancer: Insights From a Real-World Study by the Indian Gynecologic-Onco Study Group Cureus
Published: Aug. 23, 2025, 6:05 a.m.
Cumulative Abdominal Obesity Raises Young Women’s Cancer Risk - BIOENGINEER.ORG
Cumulative Abdominal Obesity Raises Young Women’s Cancer Risk BIOENGINEER.ORG
Published: Aug. 22, 2025, 7:26 p.m.
Cumulative abdominal obesity exposure and progressive risk of endometrial cancer in young women: a nationwide cohort study - Nature
Cumulative abdominal obesity exposure and progressive risk of endometrial cancer in young women: a nationwide cohort study Nature
Published: Aug. 22, 2025, 6:50 p.m.
BioNTech’s Promising Phase III Study in Recurrent Endometrial Cancer - TipRanks
BioNTech’s Promising Phase III Study in Recurrent Endometrial Cancer TipRanks
Published: Aug. 22, 2025, 4:17 p.m.
Link copied to clipboard!